Clinical Trial Update: Randomized, Double-Blind, Placebo-Controlled, With PHX1149 in Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phenomix completed a randomized, double-blind, placebo-controlled Phase 2 study of PHX1149 in adults with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PHX1149

Snippet

Sponsor: Phenomix | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED